Product
SR-T100
1 clinical trial
1 indication
Indication
Common WartClinical trial
A Double-blind, Randomized, Vehicle-controlled, Parallel-group, Phase II Dose-ranging Study to Evaluate the Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients.Status: , Estimated PCD: 2033-04-01